NCT06749275

Brief Summary

This project aims to provide an effective solution for root caries lesions (RCLs), specifically in older persons with cognitive impairment through a non-invasive therapy with Silver Diamine Fluoride (SDF). We hypothesize that, due to its remineralizing potential and the cariostatic effect conferred by silver, 38% SDF (biannually applied) will be more effective than 5,000 ppm fluoride toothpastes or 22,600 ppm fluoride varnish in preventing and arresting RCLs in older adults with cognitive impairment. The aim of this project, therefore, is to compare the effectiveness of 38% SDF with high-fluoride toothpaste of 5,000 ppm and 5% fluoride varnish of 22,600 ppm, on the incidence and inactivation of RCLs in older adults with mild cognitive impairment. A double-blind randomized controlled clinical trial (RCT) will be conducted. One hundred thirty-two 65-year-old or older participants diagnosed as having mild cognitive impairment will be invited to participate. To be eligible, subjects must have at least 5 teeth and 1 active RCLs. Participating older adults with moderate or severe cognitive impairment, dementia, severe dependency, terminal illness, aggressive behavior and alcoholism, will be excluded from the study. Included subjects will be randomly assigned to one of the 3 following study arms (n=44 per group):

  • Group 1 (Control): Toothbrushing twice per day with 5,000 ppm fluoride toothpaste
  • Group 2: Applications of 5% fluoride varnish (22,600 ppm) every 3 months + toothbrushing twice per day with 1,450 ppm fluoride toothpaste.
  • Group 3: Biannual applications of 38% SDF solution + toothbrushing twice per day with 1,450 ppm fluoride toothpaste. Incidence and lesion inactivation (arrest) using Nyvad's criteria for RCLs will be the primary outcomes to assess the effectiveness of the treatments. Clinical assessment every 6 months up to 2 years will be carried out. RCL incidence and Relative Risk (RR) will be obtained and compared among the treatment groups. This project will contribute novel scientific evidence on the effectiveness of SDF as a non-invasive therapy for RCLs with special focus on the increasing elderly population with cognitive impairment. The results of this project can be readily translated into dental practice to provide an effective and low-cost non-invasive tool to treat RCLs in cognitive impaired population, with potential implications in public health.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
179

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 12, 2021

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2023

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

December 19, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 27, 2024

Completed
Last Updated

December 27, 2024

Status Verified

December 1, 2024

Enrollment Period

2.6 years

First QC Date

December 19, 2024

Last Update Submit

December 19, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Root caries

    Activity status of root caries lesions will be clinically assessed

    at 6, 12, 18 and 24 months

Study Arms (3)

5,000 ppm fluoride toothpaste

ACTIVE COMPARATOR

Toothbrushing twice per day with 5,000 ppm fluoride toothpaste + individualized Oral Hygiene Instruction (OHI). Toothpaste of 5,000 ppm of fluoride are considered as the control, since according to international clinical guidelines (Slayton et al. 2018) it would be the treatment of choice to treat RCLs.

Device: 5,000 ppm fluoride toothpaste

22,600 ppm fluoride varnish

EXPERIMENTAL

Applications of 5% fluoride varnish (22,600 ppm) every 3 months + toothbrushing twice per day with 1,450 ppm fluoride toothpaste + individualized OHI.

Device: 22,600 ppm fluoride varnish

38% SDF

EXPERIMENTAL

Biannual applications of 38% SDF solution + toothbrushing twice per day with 1,450 ppm fluoride toothpaste + individualized OHI.

Device: 38% SDF

Interventions

In group 1, toothbrushing with toothpaste of 5,000 ppm of fluoride twice per day for two minutes, after breakfast and before bedtime. Participants will be also instructed not to rinse with water after brushing and to only eliminate the excess of the dentifrice by spitting out. The amount of toothpaste to be used had to be about the size of a pea.

Also known as: Caristop 5,000 ppm
5,000 ppm fluoride toothpaste

The application protocol of 5% fluoride varnish will be used together with the 1,450 ppm paste with the same protocol of the group 1: toothbrushing with toothpaste of 1.450 ppm of fluoride twice per day for two minutes, after breakfast and before bedtime. Participants will be also instructed not to rinse with water after brushing and to only eliminate the excess of the dentifrice by spitting out. The amount of toothpaste to be used had to be about the size of a pea.

Also known as: Duraphat 22.600 ppm
22,600 ppm fluoride varnish
38% SDFDEVICE

The application protocol of 38% SDF annually will be used together with the 1,450 ppm paste with the same protocol of the group 2: toothbrushing with toothpaste of 1.450 ppm of fluoride twice per day for two minutes, after breakfast and before bedtime. Participants will be also instructed not to rinse with water after brushing and to only eliminate the excess of the dentifrice by spitting out. The amount of toothpaste to be used had to be about the size of a pea.

Also known as: Fagamin 44,800 ppm
38% SDF

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • People 65 years of age or older, with regular attendance at the Amancay day center at least once a week or belonging to the subsample with mild cognitive impairment of the MAUCO cohort.
  • Medical diagnosis of mild cognitive impairment previously made by the psychiatrist of the Amancay team or by the MAUCO study and based on the diagnostic criteria of the International Association of Psychogeriatrics (Levy 1994).
  • Have at least 5 teeth in the mouth and 1 active RCLs, according to the methodology of previous studies (León et al. 2019; Tan et al. 2010).
  • To be able to do the toothbrushing yourself or, if you cannot do it, allow the person in charge to do it.

You may not qualify if:

  • Severe dependent older adults and terminal patients (determined according to information from the Amancay team or by the MAUCO study).
  • Aggressive older adults (who present aggressive or risky attitudes towards a member of the research team during visits).
  • Alcoholic older adults (determined according to information from the Amancay team or by the MAUCO study).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry

Talca, Maule Region, 3460000, Chile

Location

MeSH Terms

Conditions

Root CariesCognitive Dysfunction

Condition Hierarchy (Ancestors)

Dental CariesTooth DemineralizationTooth DiseasesStomatognathic DiseasesCognition DisordersNeurocognitive DisordersMental Disorders

Study Officials

  • Soraya León Araya, PhD

    University of Talca

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Fluoridated products and the different concentrations of toothpastes will be camouflaged and labeled by a member of the research team that does not participate in the clinical study who will keep them in separate boxes prior to delivery. The principal investigator and the outcomes assessor will not know the treatment received.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The total sample (132 individuals) will be divided randomly into 3 groups (44 per group) by means of a listing and using the online software http://www.random.org/ following a simple 1: 1: 1 assignment procedure in each group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

December 19, 2024

First Posted

December 27, 2024

Study Start

April 12, 2021

Primary Completion

October 31, 2023

Study Completion

October 31, 2023

Last Updated

December 27, 2024

Record last verified: 2024-12

Locations